Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22995650 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Aprepitant in the Management of Biological Therapies-related Severe Pruritus
Condition: ITCH
Interventions: Drug: Aprepitant;   Drug: Prednisone;   Drug: Fexofenadine

Indicates status has not been verified in more than two years